000			01927 a2200565 4500
005			20250515181634.0
264		0	_c20091015
008			200910s 0 0 eng d
022			_a1607-8454
024	7		_a10.1179/102453309X426245 _2doi
040			_aNLM _beng _cNLM
100	1		_aSonmez, Mehmet
245	0	0	_aEffect of LMO2 protein expression on survival in chronic myeloid leukemia patients treated with imatinib mesylate. _h[electronic resource]
260			_bHematology (Amsterdam, Netherlands) _cAug 2009
300			_a220-3 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdaptor Proteins, Signal Transducing
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBenzamides
650	0	4	_aDNA-Binding Proteins _xbiosynthesis
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aLIM Domain Proteins
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy
650	0	4	_aMale
650	0	4	_aMetalloproteins _xbiosynthesis
650	0	4	_aMiddle Aged
650	0	4	_aPiperazines _xtherapeutic use
650	0	4	_aPrognosis
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aProto-Oncogene Proteins _xbiosynthesis
650	0	4	_aPyrimidines _xtherapeutic use
650	0	4	_aSurvival Rate
650	0	4	_aYoung Adult
700	1		_aAkagun, Tulin
700	1		_aCobanoglu, Umit
700	1		_aTopbas, Murat
700	1		_aErkut, Nergiz
700	1		_aYilmaz, Mustafa
700	1		_aOvali, Ercument
700	1		_aOmay, Serdar Bedii
773	0		_tHematology (Amsterdam, Netherlands) _gvol. 14 _gno. 4 _gp. 220-3
856	4	0	_uhttps://doi.org/10.1179/102453309X426245 _zAvailable from publisher's website
999			_c19043322 _d19043322